Skip to main content

Month: January 2024

Q1 shows a challenging start of the year, as expected. However, RTX reached a significant milestone with the signing of a strategic agreement in the Healthcare Segment.

Nørresundby, Denmark, 25 January 2024Announcement no. 06/2024 Interim report for Q1 2023/24(the period 01.10.2023 – 31.12.2023)“In Q1, RTX reached a significant milestone with the signing of a strategic collaboration agreement, which can enable significant growth in the Healthcare segment of 100-200% by 2025-26. During Q1, RTX also experienced the consequences of high product inventory levels at our customers leading to low order intake and revenue. This is as expected and in line with what we communicated in our annual report in November 2023. We gradually see improvement in product demand, and we maintain strong relations with our large global customers, who have a long-term commitment and show continued interest in developing new business with RTX. As already communicated, 2023/24 will be a challenging year, but we believe business...

Continue reading

Valley National Bancorp Reports Fourth Quarter 2023 Results

NEW YORK, Jan. 25, 2024 (GLOBE NEWSWIRE) —  Valley National Bancorp (NASDAQ:VLY), the holding company for Valley National Bank, today reported net income for the fourth quarter 2023 of $71.6 million, or $0.13 per diluted common share, as compared to the fourth quarter 2022 net income of $177.6 million, or $0.34 per diluted common share, and net income of $141.3 million, or $0.27 per diluted common share, for the third quarter 2023. Excluding all non-core items, our adjusted net income (a non-GAAP measure) was $116.3 million, or $0.22 per diluted common share, for the fourth quarter 2023, $182.9 million, or $0.35 per diluted common share, for the fourth quarter 2022, and $136.4 million, or $0.26 per diluted common share, for the third quarter 2023. See further details below, including a reconciliation of our adjusted net income...

Continue reading

Stock Yards Bancorp to Participate in the Janney Annual CEO Forum

LOUISVILLE, Ky., Jan. 25, 2024 (GLOBE NEWSWIRE) — Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, today announced that Ja Hillebrand, Chairman and CEO, and T. Clay Stinnett, EVP and CFO, will participate in the Janney Annual CEO Forum to be held January 31st to February 1st, and will participate in a series of meetings with institutional investors. Management’s discussion materials to be used at this conference will be posted to the investor section of the Company’s website, www.syb.com, on or before January 31, 2024. Louisville, Kentucky-based Stock Yards Bancorp, Inc., with $8.17 billion in assets, was incorporated in 1988 as a bank...

Continue reading

Plato Gold Announces Results of 2-Hole Drill Program on the Marriott Gold Property, Matheson, Ontario

Toronto, ON, Jan. 25, 2024 (GLOBE NEWSWIRE) — Plato Gold Corp. (TSX-V: PGC) (OTCQB: NIOVF) (Frankfurt: 4Y7 or WKN: A0M2QX) (“Plato” or the “Company”) is pleased to announce the results of its 2023 winter drill program totalling 419 m and 2 drill holes on the Marriott Gold Property, Matheson, Northeastern Ontario. The Marriott Property is located within the Abitibi Greenstone Belt gold mining camp. Plato’s 2023 drill holes are located 11 km east of Agnico Eagle’s Holt gold mining complex. The Marriott drill core displays typical characteristics of Abitibi gold deposits with elevated sulphides and base metals contents:Disseminated sulphides up to 35% in blue basaltic breccia (Figure 1) Disseminated sulphides up to 2% in massive basalt and brecciated basalt Up to 7% pyrite and coarse-grained pyrite up to 2 x 3 cm in size in brecciated...

Continue reading

The Bank of Bennington Expands Partnership with nCino to Include Consumer Lending

Community bank brings together lines of business from mortgage to consumer to harness benefits of a single platform WILMINGTON, N.C., Jan. 25, 2024 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking for the global financial services industry, today announced that The Bank of Bennington (Bennington) has adopted nCino’s Consumer Banking Solution, expanding its established relationship with nCino and driving an omnichannel experience across the Bank’s personal banking and mortgage lending business. After seeing efficiency gains in its mortgage operations as a result of its use of nCino’s Mortgage Suite, Bennington saw the value in utilizing a single platform across business lines and made the strategic decision to implement the nCino Consumer Banking Solution. By combining nCino’s cloud-based solutions with...

Continue reading

Taboola to Release Fourth Quarter 2023 Financial Results and Host Earnings Conference Call on February 28, 2024

NEW YORK, Jan. 25, 2024 (GLOBE NEWSWIRE) — Taboola (Nasdaq: TBLA), a global leader in powering recommendations for the open web, today announced that it will release fourth quarter 2023 financial results on Wednesday, February 28, 2024 before market open, followed by a conference call and webcast at 8:30 a.m. ET that same day. Conference call details below: What: Taboola Fourth Quarter 2023 Financial Results Conference Call When: Wednesday, February 28, 2023 at 8:30 a.m. ET Details: Taboola’s senior management team will discuss the Company’s earnings on a call that can be accessed via webcast at https://investors.taboola.com. To access the call by phone, please go to this link to register at https://register.vevent.com/register/BI393f7d9c14614552954ce19d1ff0c2df and you will be provided with dial in details. The webcast...

Continue reading

Knight Therapeutics Enters into Exclusive License Agreement with Amneal Pharmaceuticals for IPX203

MONTREAL, Jan. 25, 2024 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has entered into an exclusive license agreement with Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal”), granting Knight the exclusive rights to seek regulatory approval and commercialize IPX203 in Canada and Latin America. IPX203 is a novel, oral formulation of carbidopa/levodopa (CD/LD) extended-release capsules designed for the treatment of Parkinson’s disease. Financial terms of the agreement were not disclosed. IPX203 contains immediate-release (IR) granules and extended-release (ER) coated beads. The IR granules consist of CD and LD, with a disintegrant polymer to allow for rapid dissolution. The ER beads consist of LD, coated...

Continue reading

Agrify Announces the Result of its Reconvened Annual Meeting, At Premium $3.9 Million Debt Conversion, and the Exercise of a Majority of Previously Issued Warrants

TROY, Mich., Jan. 25, 2024 (GLOBE NEWSWIRE) — Agrify Corporation (Nasdaq: AGFY) (“Agrify” or the “Company”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced that the shareholders of the Company approved an amendment to the Company’s Articles of Incorporation to increase the number of authorized shares of the Company’s common stock from 10,000,000 to 35,000,000 (the “Charter Amendment”), that all its outstanding debt held by CP Acquisitions LLC (the “New Lender”), an entity affiliated with Raymond Chang, the Chief Executive Officer of the Company and a member of the Board of Directors (the “Board”), and I-Tseng Jenny Chan, a member of the Board, has been consolidated under a single convertible note and approximately $3.9 million of the outstanding debt has been converted...

Continue reading

Cytokinetics Presents New Data at CMR 2024 From FOREST-HCM, the Open Label Extension Clinical Trial of Aficamten

New Data Show Treatment with Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy Resulted in Favorable Structural Remodeling, Improvements in Cardiac Function and Stabilization of Fibrosis SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced new data at CMR 2024 demonstrating favorable effects on cardiac structure, function and fibrosis related to treatment with aficamten in FOREST-HCM (Follow-up, Open-Label, Research Evaluation of Sustained Treatment with Aficamten in HCM), the open label extension clinical trial of aficamten in patients with hypertrophic cardiomyopathy (HCM). In many patients with HCM, the left ventricular hypertrophy that characterizes the disease results in elevated cardiac mass, and left ventricular outflow tract (LVOT) obstruction...

Continue reading

BOARDWALKTECH SOFTWARE CORP ANNOUNCES EXTENSION OF PREVIOUSLY ANNOUNCED NON-BROKERED LIFE OFFERING

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CUPERTINO, CA, Jan. 25, 2024 (GLOBE NEWSWIRE) —  Boardwalktech Software Corp. (the “Company” or “Boardwalktech“) (TSXV:BWLK) (OTCQB:BWLKF) announces that it has received an extension from the TSX Venture Exchange (the “TSXV“) with respect to the duration of its previously announced private placement (the “Offering“) pursuant to the Listed Issuer Financing Exemption under Part 5A of National Instrument 45-106 – Prospectus Exemptions. The outside date for the final closing and filing of all final documentation in respect of the Offering has been extended from January 25, 2024 to February 24, 2024. For more information about the upsized Offering please refer to the Company’s press...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.